High-density lipoprotein: a potent inhibitor of inflammation.
about
High density lipoprotein and metabolic disease: Potential benefits of restoring its functional propertiesAnti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cellsCholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemiaCitrulline increases cholesterol efflux from macrophages in vitro and ex vivo via ATP-binding cassette transporters.Effects of fibrates on C-reactive protein concentrations: a meta-analysis of randomized controlled trials.Lipoproteins and lipoprotein metabolism in periodontal disease.High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.Apolipoprotein A-I attenuates palmitate-mediated NF-κB activation by reducing Toll-like receptor-4 recruitment into lipid raftsAltered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome.Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activityLipoprotein subfractions by nuclear magnetic resonance are associated with tumor characteristics in breast cancer.Mild hypercholesterolemia blunts the proinflammatory and prothrombotic effects of hypertension on the cerebral microcirculation.Molecules that mimic apolipoprotein A-I: potential agents for treating atherosclerosis.Advances in stroke care and research in 2010.High-density lipoproteins as modulators of endothelial cell functions: alterations in patients with coronary artery disease.Is In-Stent Restenosis After a Successful Coronary Stent Implantation Due to Stable Angina Associated With TG/HDL-C Ratio?Usefulness of the monocyte-to-high-density lipoprotein cholesterol ratio to predict bare metal stent restenosis.Decreased high density lipoprotein cholesterol is an independent predictor for persistent organ failure, pancreatic necrosis and mortality in acute pancreatitisFrontiers in research series: Physiological and pathological functions of high-density lipoprotein. Introduction.Oxidative Stress in Human Atherothrombosis: Sources, Markers and Therapeutic Targets.Monocyte Count/HDL Cholesterol Ratio and Cardiovascular Disease in Patients With Obstructive Sleep Apnea Syndrome: A Multicenter Study.A triglyceride-rich lipoprotein environment exacerbates renal injury in the accelerated nephrotoxic nephritis model.Analysis of Factors Associated with the Severity of Acute Pancreatitis according to Etiology.Elevated Monocyte to High-Density Lipoprotein Cholesterol Ratio and Endothelial Dysfunction in Behçet Disease.Proteomics and metabolomics in biomarker discovery for cardiovascular diseases: progress and potential.A New Inflammatory Marker: Elevated Monocyte to HDL Cholesterol Ratio Associated with Smoking.Association of Monocyte-to-HDL Cholesterol Ratio with Slow Coronary Flow is Linked to Systemic Inflammation.
P2860
Q26750603-1325C8EF-F5AE-424A-A1DA-1CDCEECFABEEQ27012536-AC77C1B3-94FE-4C9A-A00C-5BA9B049DD77Q27013494-E7B42D1E-44E7-42F9-A4F4-2D9A3A1B83F6Q33832039-9E5F45D4-D296-4AD6-A1F4-B4CC4B356138Q34068794-D6735F48-6B7C-4485-9785-41A59D989331Q34106350-7C0CAB0F-FF96-4C98-B362-CA82AFFCE84AQ34157008-2224E396-0C8D-4CAC-A2ED-D92333BA1D8CQ34221770-E6CABE92-C7B8-4974-975D-39963293DC77Q36179991-2E2498BF-70CC-4064-8BB8-B6E9C0186243Q36481842-ECFCBC2A-2D31-4E3A-98EC-57DE5D00584FQ36680439-A230FBAD-AA77-4EF3-8D73-F6D358909841Q36745079-49A2AEDA-3004-4EDB-B46A-631909A7A7E1Q37671683-E198C5D9-E6C6-4580-A75C-A80AD8500FD8Q37896682-3E5CF0D6-B145-4770-90D0-65C68821C738Q38220761-A699CDDA-EAA4-4C80-AAE7-A6FCDB6CF43FQ39031322-93709239-941D-4F5F-B87B-9506B31CD4A5Q39478030-2AA64213-3A62-4BE8-BB38-75C2A03C44EDQ41387601-CCF56C27-6830-46EE-BD9F-55AD3D327FB5Q43107202-E0A70EDF-E4C6-49D3-B8AE-9B8BC989D5AEQ46269480-E5B9736D-B74B-416E-B137-8AE898141963Q47794730-841CDEC2-EC67-4926-8C34-43240AFA3959Q48100272-20420AA8-AC25-423F-B2AC-620B2816169BQ48180687-68E10FEC-B357-48B8-A32B-C5005B833DBDQ48259981-AFB2F3B2-262D-47EF-9E03-9F1F5F21D450Q51615648-9585BC2F-547F-4FDE-A1BF-89C521E5EA33Q52593556-A7CDB4F5-6CB0-4C88-B5F0-9D2899644618Q53441738-DBE0130B-8716-46A2-AFBE-FAD35B689D01
P2860
High-density lipoprotein: a potent inhibitor of inflammation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
High-density lipoprotein: a potent inhibitor of inflammation.
@en
High-density lipoprotein: a potent inhibitor of inflammation.
@nl
type
label
High-density lipoprotein: a potent inhibitor of inflammation.
@en
High-density lipoprotein: a potent inhibitor of inflammation.
@nl
prefLabel
High-density lipoprotein: a potent inhibitor of inflammation.
@en
High-density lipoprotein: a potent inhibitor of inflammation.
@nl
P2860
P921
P1476
High-density lipoprotein: a potent inhibitor of inflammation.
@en
P2093
Andrew J Murphy
P2860
P304
P356
10.1111/J.1440-1681.2009.05338.X
P577
2009-11-21T00:00:00Z